European Parliament - EU Strategy on COVID-19 vaccines must guarantee safety and accessibility for all

22 June 2020 |

Parliament's Committee responsible for public health debated how to support efforts to develop and manufacture COVID-19 vaccines, together with Commissioner Kyriakides.

  • Commission proposes a temporary derogation from clinical trials involving GMOs 
  • The Vaccine Alliance by four EU member states complementary to EU Strategy 
  • Communication on the “risk of a second wave” issued by Commission on 15 July 

Read more at the link below.

RELATED LINKS

About Us
Profile
Board of Directors
Stakeholder Network
Contact

LOGIN